A quality-by-design approach that defines potential viral contaminants of source materials can be used to achieve viral clearance.
Kathryn Martin Remington
Advertisement
Kathryn Martin Remington, PhD, is a principal scientist, development services with BioReliance by SAFC, Rockville, MD.
Articles by Kathryn Martin Remington
Advertisement
Latest Updated Articles
Application of Quality by Design to Viral SafetyOctober 1st 2014
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
2
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
3
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
4
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
5